Science

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang/LinkedIn

Mar 4, 2025, 05:27

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang, Professor of Microbiology, Immunology and Molecular Genetics at University of California, Los Angeles (UCLA), shared her recent article on LinkedIn:

“January 17, 2025- Our protocol article is published on Nature Protocols, reporting generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture.

Congratulations to all the authors, in particular the co-first authors Yan-Ruide (Charlie) Li, Kuangyi (Coin) Zhou, and Derek Lee!”

Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture

Authors: Yan-Ruide Li, et al.

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

allogeneic cancer CAR-NKT cells Derek Lee fight against cancer Global fight against cancer immunology immunotherapy Kuangyi (Coin) Zhou Lili Yang Microbiology Molecular Genetics Nature Protocols OncoDaily Oncology UCLA University of California Yan-Ruide (Charlie) Li

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

Landmark Merger Launches First Institute Dedicated to Aging and Cancer

Gevorg Tamamyan: A Story Everyone Must Read

Top 10 Oncogrants of the Week: Advancing Breakthroughs in Cancer Care

Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025